Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France. (NCT06020443) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.
France126 participantsStarted 2023-11-06
Plain-language summary
The main objective of the study is to measure adherence to a lung cancer screening program using low-dose thoracic CT.
Who can participate
Age range50 Years – 74 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 50 to 74 years
* Smoking OR having smoked (withdrawal of \<15 years): ≥15 cigarettes/day for ≥25 years OR ≥10 cigarettes/day for ≥30 years
* Affiliated or beneficiary of a social security scheme
* Written informed consent
Exclusion Criteria:
* Inability to walk up two flights of stairs without stopping
* BMI \> 35 kg/m²
* Recent chest CT scan \< 1 year
* Personal history of lung cancer \< 5 years or under treatment
* Personal history of cancer being monitored by chest CT scan
* Contraindication to lung cancer treatment or diagnostic investigations
* Current or recent respiratory symptoms immediately suggestive of lung cancer
* Pregnant or breast-feeding woman
* Person under court protection, guardianship or curatorship
* Person deprived of liberty by judicial or administrative decision.
What they're measuring
1
Rate of included patients having undergone the first screening scan
Timeframe: T0
Trial details
NCT IDNCT06020443
SponsorGroupe Hospitalier de la Region de Mulhouse et Sud Alsace